世界のポイントオブケア分子診断市場予測2019-2028

◆英語タイトル:GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2028
◆商品コード:INK20AG006
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年8月
◆ページ数:186
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、ポイントオブケア分子診断の世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、技術別(高分子鎖反応、等温核酸増幅技術、その他)分析、製品別分析、用途別分析、エンドユーザー別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・ポイントオブケア分子診断の世界市場規模:技術別(高分子鎖反応、等温核酸増幅技術、その他)
・ポイントオブケア分子診断の世界市場規模:製品別
・ポイントオブケア分子診断の世界市場規模:用途別
・ポイントオブケア分子診断の世界市場規模:エンドユーザー別
・ポイントオブケア分子診断の世界市場規模:地域別
・企業情報











【レポートの概要】

KEY FINDINGS
The global molecular point of care diagnostics market is projected to register growth at a CAGR of 14.90% during the forecast period, 2019-2028. The growing demand from several governments in terms of COVID-19 diagnosis, the rising number of diseases, increasing funding for research and development, and technological advancements, are among the primary factors that propel market growth.

MARKET INSIGHTS
The idea behind the molecular point of care diagnostics is the same as that of evaluating the health of a person at the molecular level through the detection and measurement of specific genetic signature in DNA or RNA at the site of care. The demand for advanced healthcare services has increased over the years. The non-invasive diagnosis tests have gained a fair amount of success in recent years. The physicians across the world are recommending non-invasive diagnosis, having acknowledged its potential. The non-invasive methods like liquid biopsy and NIPT are estimated to be conducive fields, in terms of investments and growth opportunities. Also, many government organizations are contributing considerably to research in non-invasive methods. As a result, the increasing demand for non-invasive diagnosis is projected to propel the global molecular point of care diagnostics market growth in the coming years.
The market players are hesitating to invest in the market, given the requirement of high investment and infrastructure. This is one of the main factors restraining the growth of the market. The competition among the market players is deemed to be high during the forecast period. It entails the players competing for harboring the largest market share.

REGIONAL INSIGHTS
The global molecular point of care diagnostics market is geographically segmented into Asia Pacific, Europe, North America, and the rest of the world. The region of North America is predicted to dominate the global market, while the Asia Pacific region is estimated to record the highest CAGR, by the end of the forecast period. The factors attributed to the North America market prospects are technological advancements impacting the scope of molecular diagnostics, along with advancements in research and development projects.

COMPETITIVE INSIGHTS
Some of the eminent market players having their presence in the market include, Abacus Diagnostica, Biocartis NV, BioMérieux SA, Danaher Corporation, Abbott Laboratories, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. DEMAND FROM GOVERNMENTS FOR DIAGNOSING COVID-19 POSITIVE PATIENTS
3.2.2. RISE IN DEMAND FOR NON-INVASIVE DIAGNOSIS
3.2.3. GROWTH IN THE NUMBER OF DISEASES
3.2.4. FUNDING FOR RESEARCH AND DEVELOPMENT
3.2.5. TECHNOLOGICAL ADVANCEMENTS IN THE MARKET
3.3. KEY RESTRAINTS
3.3.1. HIGH CAPITAL REQUIREMENT
3.3.2. LACK OF HIGH COMPLEXITY TESTING CENTERS
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. REGULATORY FRAMEWORK
4.5.1. UNITED STATES
4.5.2. EUROPE
4.5.3. ASIA-PACIFIC
5. MARKET BY TECHNOLOGY
5.1. POLYMERASE CHAIN REACTION
5.1.1. REAL TIME PCR
5.1.2. DIGITAL PCR
5.2. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY
5.3. OTHER
6. MARKET BY PRODUCT
6.1. ASSAYS
6.2. INSTRUMENTS
6.3. SOFTWARE
7. MARKET BY APPLICATION
7.1. INFECTIOUS DISEASE
7.1.1. RESPIRATORY
7.1.2. HOSPITAL ACQUIRED INFECTIONS
7.1.3. SEXUALLY TRANSMITTED INFECTIONS
7.1.4. GASTRO INTESTINAL INFECTIONS
7.2. ONCOLOGY
7.3. PRENATAL
7.4. OTHERS
8. MARKET BY END-USER
8.1. HOSPITALS
8.2. CLINICS
8.3. DIAGNOSTICS CENTRES
8.4. OTHERS
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. UNITED STATES
9.1.2. CANADA
9.2. EUROPE
9.2.1. UNITED KINGDOM
9.2.2. GERMANY
9.2.3. FRANCE
9.2.4. ITALY
9.2.5. RUSSIA
9.2.6. BELGIUM
9.2.7. POLAND
9.2.8. REST OF EUROPE
9.3. ASIA PACIFIC
9.3.1. CHINA
9.3.2. JAPAN
9.3.3. INDIA
9.3.4. SOUTH KOREA
9.3.5. INDONESIA
9.3.6. THAILAND
9.3.7. VIETNAM
9.3.8. AUSTRALIA & NEW ZEALAND
9.3.9. REST OF ASIA PACIFIC
9.4. REST OF WORLD
9.4.1. LATIN AMERICA
9.4.2. MIDDLE EAST & AFRICA
10. COMPANY PROFILES
10.1. ABBOTT LABORATORIES
10.2. ABACUS DIAGNOSTICA
10.3. BIOMÉRIEUX SA
10.4. BIOCARTIS NV
10.5. DANAHER CORPORATION
10.6. DIASORIN SPA
10.7. BIO-RAD
10.8. F HOFFMANN-LA ROCHE AG
10.9. LUMINEX CORPORATION
10.10. HOLOGIC INC
10.11. MESA BIOTECH
10.12. SPARTAN BIOSCIENCES INC
10.13. QUANTUMDX GROUP LTD
10.14. QUIDEL CORPORATION
10.15. QIAGEN NV

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - MOLECULAR POINT OF CARE DIAGNOSTICS
TABLE 2: EMERGENCY USE AUTHORISATION FOR DIAGNOSTICS BY FDA
TABLE 3: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 4: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 5: GLOBAL POLYMERASE CHAIN REACTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 6: GLOBAL POLYMERASE CHAIN REACTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 7: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PCR TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 8: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PCR TECHNOLOGY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 9: GLOBAL REAL TIME PCR MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 10: GLOBAL REAL TIME PCR MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 11: GLOBAL DIGITAL PCR MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: GLOBAL DIGITAL PCR MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 13: GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 15: GLOBAL OTHER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 16: GLOBAL OTHER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 17: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 19: GLOBAL ASSAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 20: GLOBAL ASSAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 21: GLOBAL INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 22: GLOBAL INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 23: GLOBAL SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 24: GLOBAL SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 25: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 26: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 27: GLOBAL INFECTIOUS DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 28: GLOBAL INFECTIOUS DISEASE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 29: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY INFECTIOUS DISEASE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 30: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY INFECTIOUS DISEASE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 31: GLOBAL RESPIRATORY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 32: GLOBAL RESPIRATORY DISEASE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 33: GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 34: GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 35: GLOBAL SEXUALLY TRANSMITTED INFECTIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 36: GLOBAL SEXUALLY TRANSMITTED INFECTIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 37: GLOBAL GASTRO INTESTINAL INFECTIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 38: GLOBAL GASTRO INTESTINAL INFECTIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 39: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 40: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 41: GLOBAL PRENATAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 42: GLOBAL PRENATAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 43: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 44: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 45: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 46: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 47: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 48: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 49: GLOBAL CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 50: GLOBAL CLINICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 51: GLOBAL DIAGNOSTIC CENTRES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 52: GLOBAL DIAGNOSTIC CENTRES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 53: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 54: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 55: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 56: GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 57: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 58: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 59: EUROPE MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 60: EUROPE MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 61: ASIA PACIFIC MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 62: ASIA PACIFIC MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 63: REST OF WORLD MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 64: REST OF WORLD MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のポイントオブケア分子診断市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆